Trial Information
Prospective Randomized Controlled Trial of Cap-Assisted ChromoEndoscopy(CapACE) Versus Conventional Colonoscopy(CC) for the Detection and 3-year Recurrence Rate of Colorectal Neoplasia
Inclusion Criteria:
- All asymptomatic colonoscopic examinees
Exclusion Criteria:
- Familial history of hereditary colorectal cancer
- History of colorectal neoplasm
- Patients had received colonoscopy examination before
- Familial or past history of FAP(familiar adenomatous polyposis)
- Prior colonic resection
- Familial history of inflammatory bowel disease(IBD)
- Inflammatory bowel disease
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Detection rate of colorectal neoplasia
Outcome Description:
7 days is needed to confirm the pathologic examination.
Outcome Time Frame:
7 days
Safety Issue:
No
Principal Investigator
Hyun Soo Kim
Investigator Role:
Principal Investigator
Investigator Affiliation:
Korean Association for the Study of Intestinal Diseases
Authority:
Korea: Institutional Review Board
Study ID:
KASID polyp-01
NCT ID:
NCT01112280
Start Date:
April 2010
Completion Date:
August 2015
Related Keywords:
- Colorectal Neoplasm
- Colorectal neoplasm
- Colonoscopy
- chromoendoscopy
- cap-assisted colonoscopy
- Neoplasms
- Colorectal Neoplasms